Archives: News

It’s no surprise that the public hates Big Pharma. They rank just under the government on most Americans’ despised institution list.

Innoplexus is at the forefront of decision-making technology as the company works in data aggregation to provide to

We are in the midst of a significant shift in pharmaceutical drug development, with many leading companies focusing increasingly on orphan drugs targeted at small niche markets. An orphan disease is a medical condition or disorder that affects less than 200,000 people in the US. The National Institutes of Health (NIH) has classified as many …

Why AI and blockchain are the solutions to developing orphan drug Read More »

Companies that thrive on sustaining products over a long period are always at risk of classic disruptive innovation—losing business to a smaller company with fewer resources that jumps in, improves a product, makes it more affordable, and broadens its appeal to more people. Disruptive innovators create new markets and reshape existing ones. Take, for instance, …

Who will be the disruptor that pharma is waiting for? Read More »

The idea that a company’s success depends on how much it can leverage the skills of its employees’ bright minds is rapidly becoming an outdated concept. Companies that are equipped with technologies for collaborating with a vast pool of global talent will build a competitive advantage. Collaboration is essential for innovation and efficiency. Open source …

Blockchain can take pharma collaboration and innovation to new heights Read More »

Redundancies in any professional field mean dollars lost. But in healthcare, inefficiency can cost lives. That’s a reality that Gunjan Bhardwaj came to understand when his friend and mentor was diagnosed with cancer. When Bhardwaj accompanied him during grueling rounds of chemo, he was appalled at the lack of information evidence from which to draw …

New Blockchain Platform from Innoplexus Will Bring Us Better, Cheaper Drugs Read More »

In this special guest feature, Gunjan Bhardwaj, Founder and CEO of Innoplexus, discusses how data silos in pharma prevent the latest advancements in machine learning and data analytics from operating at their full potential, how AI and blockchain are transforming incentives in data sharing practices to promote greater transparency, and how companies can leverage open …

How Eliminating Data Silos Will Democratize Pharma R&D Read More »

Researchers tend to have a genuine scientific curiosity and desire to make the world better with their discoveries. They are often thrilled about laboratory experiments and preclinical studies, regardless of their outcomes. However, one big problem in scientific research is that there are only rewards for publishing “positive” outcomes. Most studies with questionable outcomes never …

Why blockchain is a dream come true for pharma researchers Read More »

The quest for innovation is a major driving force in pharma. From the discovery of therapeutic biologicals in the 1920s, such as Salvarsan and insulin, to the blockbuster drugs birthed in the 1990s, such as Lipitor and Humira, pharma has always been on a quest for novel, groundbreaking drug development. However, advancements in technology are constantly …

Four steps to building an innovation culture in pharma Read More »